BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1560431)

  • 1. Oral hypoglycemic agents. Pyrimido[1,2-a]indoles and related compounds.
    Cliffe IA; Lien EL; Mansell HL; Steiner KE; Todd RS; White AC; Black RM
    J Med Chem; 1992 Apr; 35(7):1169-75. PubMed ID: 1560431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
    Müller CE; Geis U; Grahner B; Lanzner W; Eger K
    J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimisation of novel 4, 8-disubstituted dihydropyrimido[5,4-
    Fang Y; Zhang S; Li M; Xiong L; Tu L; Xie S; Jin Y; Liu Y; Yang Z; Liu R
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):50-58. PubMed ID: 31656107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and structure-activity relationships of pyrimido[4,5-b]indole-4-amines as microtubule depolymerizing agents that are effective against multidrug resistant cells.
    Devambatla RKV; Li W; Zaware N; Choudhary S; Hamel E; Mooberry SL; Gangjee A
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3423-3430. PubMed ID: 28610978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis and insulinotropic activity of 2-benzylidenesuccinic acid derivatives].
    Gao LM; Yang P; Song DQ
    Yao Xue Xue Bao; 2005 Dec; 40(12):1122-6. PubMed ID: 16496677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of N-aryl-2-acylindole human glucagon receptor antagonists.
    Sinz C; Bittner A; Brady E; Candelore M; Dallas-Yang Q; Ding V; Jiang G; Lin Z; Qureshi S; Salituro G; Saperstein R; Shang J; Szalkowski D; Tota L; Vincent S; Wright M; Xu S; Yang X; Zhang B; Tata J; Kim R; Parmee ER
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7124-30. PubMed ID: 22030028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors.
    Onda K; Shiraki R; Ogiyama T; Yokoyama K; Momose K; Katayama N; Orita M; Yamaguchi T; Furutani M; Hamada N; Takeuchi M; Okada M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2008 Dec; 16(23):10001-12. PubMed ID: 18952447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.
    Romeo G; Materia L; Manetti F; Cagnotto A; Mennini T; Nicoletti F; Botta M; Russo F; Minneman KP
    J Med Chem; 2003 Jul; 46(14):2877-94. PubMed ID: 12825930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indole-2-carboxamide inhibitors of human liver glycogen phosphorylase.
    Hoover DJ; Lefkowitz-Snow S; Burgess-Henry JL; Martin WH; Armento SJ; Stock IA; McPherson RK; Genereux PE; Gibbs EM; Treadway JL
    J Med Chem; 1998 Jul; 41(16):2934-8. PubMed ID: 9685232
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of substituted pyrimido[5,4-b]indoles as selective Toll-like receptor 4 ligands.
    Chan M; Hayashi T; Mathewson RD; Nour A; Hayashi Y; Yao S; Tawatao RI; Crain B; Tsigelny IF; Kouznetsova VL; Messer K; Pu M; Corr M; Carson DA; Cottam HB
    J Med Chem; 2013 Jun; 56(11):4206-23. PubMed ID: 23656327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of substituted-N-(thieno[2,3-b]pyridin-3-yl)-guanidines, N-(1H-pyrrolo[2,3-b]pyridin-3-yl)-guanidines, and N-(1H-indol-3-yl)-guanidines.
    Bahekar RH; Jain MR; Goel A; Patel DN; Prajapati VM; Gupta AA; Jadav PA; Patel PR
    Bioorg Med Chem; 2007 May; 15(9):3248-65. PubMed ID: 17339113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycemic activity of curcumin synthetic analogues in alloxan-induced diabetic rats.
    Das KK; Razzaghi-Asl N; Tikare SN; Di Santo R; Costi R; Messore A; Pescatori L; Crucitti GC; Jargar JG; Dhundasi SA; Saso L
    J Enzyme Inhib Med Chem; 2016; 31(1):99-105. PubMed ID: 25683079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel euglycemic and hypolipidemic agents. 1.
    Lohray BB; Bhushan V; Rao BP; Madhavan GR; Murali N; Rao KN; Reddy AK; Rajesh BM; Reddy PG; Chakrabarti R; Vikramadithyan RK; Rajagopalan R; Mamidi RN; Jajoo HK; Subramaniam S
    J Med Chem; 1998 May; 41(10):1619-30. PubMed ID: 9572887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione.
    Lee HW; Kim BY; Ahn JB; Kang SK; Lee JH; Shin JS; Ahn SK; Lee SJ; Yoon SS
    Eur J Med Chem; 2005 Sep; 40(9):862-74. PubMed ID: 15908051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and SAR studies of bicyclic amine series GPR119 agonists.
    Sakairi M; Kogami M; Torii M; Kataoka H; Fujieda H; Makino M; Kataoka D; Okamoto R; Miyazawa T; Okabe M; Inoue M; Takahashi N; Harada S; Watanabe N
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5123-8. PubMed ID: 22765901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of novel spiro derivatives for pyrrolopyrimidines as anti-hyperglycemia promising compounds.
    Fatahala SS; Mahgub S; Taha H; Abd-El Hameed RH
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):809-817. PubMed ID: 29708461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 4-amino-7,8-dimethoxy-5H-pyrimido[5,4-b]indole derivatives: synthesis and studies as inhibitors of phosphodiesterases.
    Monge A; Martínez-Crespo FJ; Villanueva MA; Font M; Santiago E; Martínez de Irujo JJ; Alberdi E; López-Unzu MJ; Cenarruzabeitia E; Castiella E
    Arch Pharm (Weinheim); 1993 Nov; 326(11):879-85. PubMed ID: 8274070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-, 1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines and isosteric analogues of imidazoline.
    Le Bihan G; Rondu F; Pelé-Tounian A; Wang X; Lidy S; Touboul E; Lamouri A; Dive G; Huet J; Pfeiffer B; Renard P; Guardiola-Lemaître B; Manéchez D; Pénicaud L; Ktorza A; Godfroid JJ
    J Med Chem; 1999 May; 42(9):1587-603. PubMed ID: 10229628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Activity Relationship Studies of Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands.
    Chan M; Kakitsubata Y; Hayashi T; Ahmadi A; Yao S; Shukla NM; Oyama SY; Baba A; Nguyen B; Corr M; Suda Y; Carson DA; Cottam HB; Wakao M
    J Med Chem; 2017 Nov; 60(22):9142-9161. PubMed ID: 29049886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of new thiazolylmethoxyphenyl pyrimidines and antihyperglycemic evaluation of the pyrimidines, analogues isoxazolines and pyrazolines.
    Bhosle MR; Deshmukh AR; Pal S; Srivastava AK; Mane RA
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2442-6. PubMed ID: 25937008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.